FDA approves betrixaban for hospital and extended duration prevention of VTE in acutely ill

5th July 2017 Uncategorised 0

American Pharmacists Association News

More: FDA approves betrixaban for hospital and extended duration prevention of VTE in acutely ill
Source: MDlinx